December 18, 2025

Top 10 States to Practice Obstetrics and Gynecology

The following list highlights the states that offer the most favorable conditions for obstetricians and gynecologists.

Conexiant

December 15, 2025

Genetic Testing Uncovers Hidden Cancer Risk

Population screening identifies pathogenic variants in patients who wouldn't qualify under current guidelines

Conexiant

December 15, 2025

Doctors Push Back on FDA Antidepressant Fears

After an FDA roundtable raised alarms about antidepressant use in pregnancy, physicians warn the rhetoric could fuel fear, stigma, and dangerous gaps in care.

KFF Health News

December 12, 2025

FDA Greenlights Oral Gonorrhea Treatments

Two new antibiotics offer alternatives to injectable ceftriaxone as gonococcal drug resistance spreads globally.

Conexiant

December 10, 2025

PFAS Exposure Tied to Hormone Disruption

Growing evidence links even low-level PFAS exposure to endocrine disruption, with a new study identifying n-PFOS as a leading driver of risk among women.

Conexiant

January 16, 2025

Algorithm Improves Diagnosis of Uterine Lesions

"The preoperative 3-class diagnostic algorithm and risk class system can stratify women according to risk of malignancy."

Conexiant

October 28, 2024

Single Swab Approach Assesses Co-Occurring Vaginal Infections

A recent study reveals that 80% of women with STIs may have bacterial vaginosis, highlighting the potential benefits of simultaneous STI and vaginitis testing in clinical practice.

Conexiant

December 12, 2024

Brief, Vigorous Activity May Lower CV Risk in Women: Study Findings

A recent study shows that even 3.4 minutes of vigorous intermittent lifestyle physical activity per day could significantly reduce cardiovascular risk, particularly in non-exercising women.

Conexiant

November 14, 2024

Can Botox Ease Chronic Pelvic Pain?

A recent study assessed the efficacy of Botulinum Toxin A injections in conjunction with pelvic floor muscle therapy for women with chronic pelvic pain, revealing interesting insights into its effectiveness compared to a placebo.

Conexiant